- Datum04.12.2024
- Uhrzeit15:00 - 15:30 Uhr
- Veranstalter
stock3
Bastian Galuschka
Moderator
AVINGER INC. DL-,001 Aktie
Verkaufen
Kaufen
AVINGER INC. DL-,001 Chart
stock3 TerminalDu willst selbst ins Charting einsteigen?
Nutze das Charting-Widget auf dem stock3 Terminal für Deine eigene Analyse. Mehr Features. Mehr Werkzeuge. Mehr stock3.
Chart im Terminal öffnen
AVINGER INC. DL-,001 Realtime-Kurs
| Name | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
|---|---|---|---|---|---|---|
| Nasdaq | VK | |||||
| Nasdaq Basic | VK | |||||
| Cboe BZX | VK |
Passende Produkte
| WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
|---|
Keine Ergebnisse gefunden
Wertentwicklung (Nasdaq)
2,66 %
Intraday
2,53 %
1 Woche
-9,80 %
1 Monat
-70,11 %
Seit Jahresbeginn
-73,36 %
1 Jahr
-99,61 %
3 Jahre
-99,82 %
5 Jahre
Wikifolio
Passender Service zu AVINGER INC. DL-,001
Webinar zu AVINGER INC. DL-,001
Kursinformationen (Nasdaq)
- Tagestief / Hoch ($)-
- 52W-Tief / Hoch ($)0,703-5,450
- Jahrestief / Hoch ($)0,703-5,450
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Dividenden von AVINGER INC. DL-,001
Keine Dividenden verfügbar
Termine von AVINGER INC. DL-,001
Termine werden geladen...
Beschreibung
Avinger Inc is a United States-based medical device company. It is engaged in designing, manufacturing and selling image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). The products offered by the firm include Lightbox imaging console, the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO) and Pantheris, image-guided atherectomy device which is designed to allow physicians to precisely remove arterial plaque in PAD patients. It manufactures and sells products in the United States and internationally of which it generates the majority of the revenue from the sales made in the United States.
